Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Technical Report
  • Published:

A novel assay for the measurement of Raf-1 kinase activity

Abstract

Raf-1 is a serine-threonine protein kinase that functions as a central component of the mitogen-activated protein kinase signal transduction pathway. Raf-1 activity is currently assayed in vitro by either measuring 32P incorporation into MEK, Raf-1’s only characterized substrate, or by using the phosphorylated MEK to initiate a coupled assay culminating in the phosphorylation of myelin basic protein by MAP kinase. These assays are plagued by a potential lack of specificity in the case of the former, and the time consuming and error-prone nature of the later indirect assay. In this report, we demonstrate a novel single step assay for Raf-1 kinase activity based on phosphorylation of recombinant MEK-1, detected using an activation-specific MEK antibody that recognizes MEK only when specifically phosphorylated by Raf-1 on Ser 217 and Ser 221. The assay readily detected stem cell factor-mediated Raf-1 activation. MEK phosphorylation by immunoprecipitated Raf-1 plateaued at 10 min following initiation of the kinase reaction and was completely dependent on the inclusion of Raf-1. There was a linear correlation between the degree of MEK phosphorylation and the amount of Raf-1 protein immunoprecipitated. In addition to detecting growth factor-mediated activation, the assay was also able to detect paclitaxel-mediated Raf-1 activation. This assay is rapid, sensitive, and specific and therefore is a marked improvement over currently utilized techniques.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A, Marshall CJ and Cowley S. . 1994 EMBO J. 13: 1610–1619.

  • Alessi DR, Cohen P, Ashworth A, Cowley S, Leevers SJ and Marshall CJ. . 1995 Meth. In Enzym. 255: 279–290.

  • Anborgh PH, Qian X, Papageorge AG, Vass WC, DeClue JE and Lowy DR. . 1999 Mol. Cell. Biol. 19: 4611–4622.

  • Avruch J, Zhang XF and Kyriakis JM. . 1994 Trends Biochem. Sci. 19: 279–283.

  • Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME and Huang Y. . 1993 Leukemia 7: 563–568.

  • Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J and Neckers L. . 1995 Cancer Res. 55: 4623–4626.

  • Brunet A, Pagès G and Pouysségur J. . 1994 FEBS Lett. 346: 299–303.

  • Cowley S, Paterson H, Kemp P and Marshall CJ. . 1994 Cell 77: 841–852.

  • Dent P, Haser W, Haystead TAJ, Vincent LA, Roberts TM and Sturgill TW. . 1992 Science 257: 1404–1407.

  • Fabian JR, Daar IO and Morrison DK. . 1993 Mol. Cell. Biol. 13: 7170–7179.

  • Jelinek T, Dent P, Sturgill TW and Weber MJ. . 1996 Mol. Cell. Biol. 16: 1027–1034.

  • Krystal GW, DeBerry CS, Linnekin D and Litz J. . 1998 Cancer Res. 58: 4660–4666.

  • Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR and Avruch J. . 1992 Nature 358: 417–421.

  • Kyriakis JM, Force TL, Rapp UR, Bonventre JV and Avruch J. . 1993 J. Biol. Chem. 268: 16009–16019.

  • Lewis TS, Shapiro PS and Ahn NG. . 1998 Adv. Cancer Res. 74: 49–139.

  • Lou Z, Diaz B, Marshall MS and Avruch J. . 1997 Mol. Cell. Biol. 17: 46–53.

  • Manffredi JJ and Horwitz SB. . 1984 Pharmacol. Ther. 25: 83–125.

  • Marias R, Light Y, Paterson HF and Marshall CJ. . 1995 EMBO J. 14: 3136–3145.

  • Okuda K, Sanghera JS, Pelech SL, Kanakura Y, Hallek M, Griffin JD and Drucker BJ. . 1992 Blood 79: 2880–2887.

  • Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds Jr FH and Stephenson JR. . 1983 Proc. Natl. Acad. Sci. USA. 80: 4218–4222.

  • Robinson MJ and Cobb MH. . 1997 Curr. Opin. Cell Biol. 9: 180–186.

  • Rowinsky EK, Donehower RC, Jones RJ and Tucker RW. . 1988 Cancer Res. 48: 4093–4100.

  • Roy S, Lane A, Yan J, McPherson R and Hancock JF. . 1997 J. Biol. Chem. 272: 20139–20145.

  • Saito Y, Gomez N, Campbell DG, Ashworth A, Marshall CJ and Cohen P. . 1994 FEBS Lett. 341: 119–124.

  • Torres K and Horwitz SB. . 1998 Cancer Res. 58: 3620–3626.

  • Van Aelst L, Barr M, Marcus S, Polverino A and Wigler M. . 1993 Proc. Natl. Acad. Sci. USA. 90: 6213–6217.

  • Vojtek AB, Hollenberg SM and Cooper JA. . 1993 Cell 74: 205–214.

  • Wartmann M and Davis RJ. . 1994 J. Biol. Chem. 269: 6695–6701.

  • Zheng CF and Guan KL. . 1994 EMBO J. 13: 1123–1131.

Download references

Acknowledgements

This work was supported by a Veterans Administration Merit Review Award to Geoffrey W Krystal and PHS grants CA83705 and CA63753 to Steven Grant.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bondzi, C., Grant, S. & Krystal, G. A novel assay for the measurement of Raf-1 kinase activity. Oncogene 19, 5030–5033 (2000). https://doi.org/10.1038/sj.onc.1203862

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203862

Keywords

This article is cited by

Search

Quick links